@0)
ey
@)

8

(ii)

Series B CCPS, 90,000 Equity Shares to Jayalakshmi Puppala upon conversion of 18,000 Series B CCPS, 75,600 Equity Shares to Suneel Dhawan
upon conversion of 15,120 Series B CCPS, 37,800 Equity Shares to Navdeep Patyal upon conversion of 7,560 Series B CCPS, 37,800 Equity Shares
to Ashok Mayya upon conversion of 7,560 Series B CCPS, 29,200 Equity Shares to R. Venkat Reddy upon conversion of 5,840 Series B CCPS,
91,000 Equity Shares to P Rajya Lakshmi upon conversion of 18,200 Series B CCPS, 103,600 Equity Shares to K Prakurthi upon conversion of
20,720 Series B CCPS, 78,800 Equity Shares to Sangeeta Raju upon conversion of 15,760 Series B CCPS, 9,599,800 Equity Shares to PI
Opportunities Fund-I upon conversion of 1,919,960 Series B CCPS, 1,805,400 Equity Shares to SS Pharma LLC upon conversion of 361,080 Series
B CCPS, 5,39,600 Equity Shares to Shore Pharma LLC upon conversion of 107,920 Series B CCPS, 440,200 Equity Shares to Natco Pharma
Limited upon conversion of 88,040 Series B CCPS, 4,39,600 Equity Shares to Time Cap Pharma Labs Limited upon conversion of 87,920 Series B
CCPS, 24,800 Equity Shares to TK Kurein upon conversion of 4,960 Series B CCPS, 22,600 Equity Shares to Nithya Venkataramani upon
conversion of 4,520 Series B CCPS, 22,600 Equity Shares to Atul Gupta upon conversion of 4,520 Series B CCPS, 22,600 Equity Shares to Rahul
Garg upon conversion of 4,520 Series B CCPS, 22,600 Equity Shares to Manoj Jaiswal upon conversion of 4,520 Series B CCPS, 9,000 Equity
Shares to Kollengode Ramanathan Lakshminarayana upon conversion of 1,800 Series B CCPS, 9,000 Equity Shares to Bijou Kurein upon
conversion of 1,800 Series B CCPS, 4,600 Equity Shares to Ikram Noor Jaffer upon conversion of 920 Series B CPS, 4,600 Equity Shares to
Ajitesh Murali Nair upon conversion of 920 Series B CCPS, 24,067,000 Equity Shares to Lavender Rose Investment Ltd upon conversion of
4,813,400 Series B CCPS, 1,327,000 Equity Shares to Bhaskar Reddy Cherukupalli upon conversion of 265,400 Series B CCPS, 2,70,000 Equity
Shares to Paidiwar Srinivas upon conversion of 54,000 Series B CCPS, 270,000 Equity Shares to Pradeep Yalamandala upon conversion of 54,000
Series B CCPS, 180,000 Equity Shares to Phani Srinivas Ramella upon conversion of 36,000 Series B CCPS, 1,35,000 Equity Shares to Brundaban
Dash upon conversion of 27,000 Series B CCPS, 1,35,000 Equity Shares to Satya Murali Krishna Kammila upon conversion of 27,000 Series B
COPS, 1,35,000 Equity Shares to Kandasamy Vairaperumal upon conversion of 27,000 Series B CCPS, 90,000 Equity Shares to Venugopal
Siripuram upon conversion of 18,000 Series B CCPS, 67,600 Equity Shares to Prabhakarreddy Gndlapalli upon conversion of 13,520 Series B
CCPS, 45,000 Equity Shares to Tadi Srinivasa Reddy upon conversion of 9,000 Series B CCPS, 45,000 Equity Shares to Paramesham Kasturi upon
conversion of 9,000 Series B CCPS, 45,000 Equity Shares to Prasad Reddy Battinapatla upon conversion of 9,000 Series B CCPS, 33,800 Equity
Shares to Ravi Kumar Kodali upon conversion of 6,760 Series B CCPS, 33,800 Equity Shares to Devaraj Goud Bakki upon conversion of 6,760
Series B CPS, 33,800 Equity Shares to Tubati Venkata Satyanarayana upon conversion of 6,760 Series B CCPS, 33,800 Equity Shares to Siba
Narayan Mishra upon conversion of 6,760 Series B CCPS, 33,800 Equity Shares to Tapan Majumdar upon conversion of 6,760 Series B CCPS,
33,800 Equity Shares to Subba Rao Madhavaram upon conversion of 6,760 Series B CCPS, 24,800 Equity Shares to Guntakandla Raja Shekhara
Reddy upon conversion of 4,960 Series B CCPS, 22,600 Equity Shares to Sathish Prashanth Kumar upon conversion of 4,520 Series B CCPS,
22,600 Equity Shares to Atul Dnyaneshwarrao Sawarkar upon conversion of 4,520 Series B CCPS, 22,600 Equity Shares to Reddy Kattamanchi
Umapathi upon conversion of 4,520 Series B CCPS, 22,600 Equity Shares to Kalava Raghunadha Reddy upon conversion of 4,520 Series B CCPS,
22,600 Equity Shares to Kula Sekhar Puvvada upon conversion of 4,520 Series B CCPS, 22,600 Equity Shares to Suguneswar Namala upon
conversion of 4,520 Series B CCPS, 18,000 Equity Shares to Sampath Kumar Chepuri upon conversion of 3,600 Series B CCPS, 15,800 Equity
Shares to Raja Gopal Manchiraju upon conversion of 3,160 Series B CCPS, 15,800 Equity Shares to Venkat Rao Rangineni upon conversion of
3,160 Series B CCPS, 11,200 Equity Shares to Rama Naga Srinivas Dasari upon conversion of 2,240 Series B CCPS, 11,200 Equity Shares to
Narsimha Reddy Atla upon conversion of 2,240 Series B CCPS, 11,200 Equity Shares to Raju Guntuka upon conversion of 2,240 Series B CCPS,
9,000 Equity Shares to Srinivasa Rao Penumudi upon conversion of 1,800 Series B CPS, 6,800 Equity Shares to Jajula Venkata Satyanarayana
upon conversion of 1,360 Series B CCPS, and 4,600 Equity Shares to Mohammad Zafarshah Khadari upon conversion of 920 Series B CCPS.

Allotment of 8,607,225 Equity Shares to Agilemed Investments Private Limited upon conversion of 1,721,445 Series B1 CCPS
Allotment of 28,04,480 Equity Shares to Lavender Rose Investment Ltd upon conversion of 560,896 Series C1 CCPS
Allotment of 8,543,340 Equity Shares to Lone Furrow Investments Private Limited upon conversion of 1,676,418 Series B2 CCPS

Allotment of 639,485 Equity Shares to PI Opportunities Fund — I, a category Il alternative investment fund registered under Securities and Exchange
Board of India (Alternative Investment Funds) Regulations, 2012, represented by its trustee Hasham Premji Private Limited upon conversion of
160,147 Series C2 CCPS

Preference share capital

The history of the preference share capital of our Company is set forth in the table below:

 

Date of allotment | Number of preference |Face | Issue Nature of Nature of] Cumulativ | Cumulativ
shares allotted value per| price per|consideratio | allotment |e number|e paid-up
preferen | preferenc |n of preference
ce share;e share preference | share
® ®@ shares capital

 

Series A CCPS
September 27, 2007 7,881,900 10 10 Cash Allotment | 7,881,900] 78,819,000
of Series A
ccps®
November 19, 2007 (7,881,900) 10 - NA* Conversio - -
n of Series
A CCPS
into Equity
Shares
March 16, 2019 Reclassification of preference shares from face value of 210 each to 20 each - -
‘April 10, 2019 30,747 20] 66,295.10 Cash’ Allotment 30,747| 614,940
of Series A
ccps®)
Jamuary 22, 2021 38,434 20 - NA Bonus 69,181 1,383,620
issue in the
ratio of
1.25 Series
A CCPS
for every
one Series
A CCPS
held
February 6, 2021 2,767,240 20 - NA Bonus 2,836,421 | 56,728,420
issue in the
proportion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

77
